158 related articles for article (PubMed ID: 37132595)
1. The Role of Substance P Within Traumatic Brain Injury and Implications for Therapy.
Safwat A; Helmy A; Gupta A
J Neurotrauma; 2023 Aug; 40(15-16):1567-1583. PubMed ID: 37132595
[TBL] [Abstract][Full Text] [Related]
2. Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury.
Donkin JJ; Nimmo AJ; Cernak I; Blumbergs PC; Vink R
J Cereb Blood Flow Metab; 2009 Aug; 29(8):1388-98. PubMed ID: 19436311
[TBL] [Abstract][Full Text] [Related]
3. Tachykinin NK1 receptor antagonist L-733,060 and substance P deletion exert neuroprotection through inhibiting oxidative stress and cell death after traumatic brain injury in mice.
Li Q; Wu X; Yang Y; Zhang Y; He F; Xu X; Zhang Z; Tao L; Luo C
Int J Biochem Cell Biol; 2019 Feb; 107():154-165. PubMed ID: 30593954
[TBL] [Abstract][Full Text] [Related]
4. Substance P antagonists as a therapeutic approach to improving outcome following traumatic brain injury.
Vink R; van den Heuvel C
Neurotherapeutics; 2010 Jan; 7(1):74-80. PubMed ID: 20129499
[TBL] [Abstract][Full Text] [Related]
5. NK1 receptor blockade is ineffective in improving outcome following a balloon compression model of spinal cord injury.
Leonard AV; Thornton E; Vink R
PLoS One; 2014; 9(5):e98364. PubMed ID: 24859234
[TBL] [Abstract][Full Text] [Related]
6. Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation.
Corrigan F; Mander KA; Leonard AV; Vink R
J Neuroinflammation; 2016 Oct; 13(1):264. PubMed ID: 27724914
[TBL] [Abstract][Full Text] [Related]
7. The Role of Neurogenic Inflammation in Blood-Brain Barrier Disruption and Development of Cerebral Oedema Following Acute Central Nervous System (CNS) Injury.
Sorby-Adams AJ; Marcoionni AM; Dempsey ER; Woenig JA; Turner RJ
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28817088
[TBL] [Abstract][Full Text] [Related]
8. Substance P in traumatic brain injury.
Donkin JJ; Turner RJ; Hassan I; Vink R
Prog Brain Res; 2007; 161():97-109. PubMed ID: 17618972
[TBL] [Abstract][Full Text] [Related]
9. Identification of an Intravenous Injectable NK1 Receptor Antagonist for Use in Traumatic Brain Injury.
Vink R; Nimmo A
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542509
[TBL] [Abstract][Full Text] [Related]
10. Inflammation in acute CNS injury: a focus on the role of substance P.
Corrigan F; Vink R; Turner RJ
Br J Pharmacol; 2016 Feb; 173(4):703-15. PubMed ID: 25827155
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between neurokinin receptor signaling and neuroinflammation in neurological disorders.
Eapen PM; Rao CM; Nampoothiri M
Rev Neurosci; 2019 Apr; 30(3):233-243. PubMed ID: 30260793
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments.
Donkin JJ; Vink R
Curr Opin Neurol; 2010 Jun; 23(3):293-9. PubMed ID: 20168229
[TBL] [Abstract][Full Text] [Related]
13. Central and peripheral expression of neurokinin-1 and neurokinin-3 receptor and substance P-encoding messenger RNAs: peripheral regulation during formalin-induced inflammation and lack of neurokinin receptor expression in primary afferent sensory neurons.
McCarson KE
Neuroscience; 1999; 93(1):361-70. PubMed ID: 10430499
[TBL] [Abstract][Full Text] [Related]
14. Possible involvement of neurokinin receptors in CNS and neuromuscular synapse in the realization of the effects of CAPAH and substance P.
Semina II; Bukharaeva EA; Shilovskaya EV; Baichurina AZ; Garaev RS
Bull Exp Biol Med; 2002 Sep; 134(3):267-70. PubMed ID: 12511999
[TBL] [Abstract][Full Text] [Related]
15. Substance P antagonists as a novel intervention for brain edema and raised intracranial pressure.
Gabrielian L; Helps SC; Thornton E; Turner RJ; Leonard AV; Vink R
Acta Neurochir Suppl; 2013; 118():201-4. PubMed ID: 23564132
[TBL] [Abstract][Full Text] [Related]
16. Substance P and neurokinin 1 receptor are new targets for the treatment of chronic pruritus.
Ständer S; Yosipovitch G
Br J Dermatol; 2019 Nov; 181(5):932-938. PubMed ID: 31016733
[TBL] [Abstract][Full Text] [Related]
17. C-FOS expression in the rat brain in response to substance P and neurokinin B.
Spitznagel H; Baulmann J; Blume A; Unger T; Culman J
Brain Res; 2001 Oct; 916(1-2):11-21. PubMed ID: 11597586
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of neurogenic inflammation as a novel treatment for ischemic stroke.
Turner R; Vink R
Timely Top Med Cardiovasc Dis; 2007 Oct; 11():E24. PubMed ID: 18297137
[TBL] [Abstract][Full Text] [Related]
19. Sulfonylurea Receptor-1: A Novel Biomarker for Cerebral Edema in Severe Traumatic Brain Injury.
Jha RM; Puccio AM; Chou SH; Chang CH; Wallisch JS; Molyneaux BJ; Zusman BE; Shutter LA; Poloyac SM; Janesko-Feldman KL; Okonkwo DO; Kochanek PM
Crit Care Med; 2017 Mar; 45(3):e255-e264. PubMed ID: 27845954
[TBL] [Abstract][Full Text] [Related]
20. Roles of Astrocytic Endothelin ET
Michinaga S; Hishinuma S; Koyama Y
Cells; 2023 Feb; 12(5):. PubMed ID: 36899860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
